The estimated Net Worth of Lord Ara Darzi is at least $122 Tysiąc dollars as of 27 May 2022. Lord Darzi owns over 342,465 units of Evelo Biosciences Inc stock worth over $7,705 and over the last 5 years he sold EVLO stock worth over $0. In addition, he makes $114,666 as Independent Director at Evelo Biosciences Inc.
Sign up
Lord Darzi EVLO stock SEC Form 4 insiders trading
Lord has made over 1 trades of the Evelo Biosciences Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 342,465 units of EVLO stock worth $499,999 on 27 May 2022.
The largest trade he's ever made was buying 342,465 units of Evelo Biosciences Inc stock on 27 May 2022 worth over $499,999. On average, Lord trades about 68,493 units every 0 days since 2019. As of 27 May 2022 he still owns at least 342,465 units of Evelo Biosciences Inc stock.
You can see the complete history of Lord Darzi stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Lord Ara Darzi biography
Prof. Lord Ara Darzi serves as Independent Director of the Company. Lord Darzi also currently serves on the board of directors of HQI Holdings Limited, Health Quality Improvement LLC, Ara Darzi Qatar Limited, SQI Limited and SPI Investments Limited. He also currently serves as the Vice Chair of the Board of Governors of Sidra Medical and Research Center, Qatar, a Council Member at the Engineering and Physical Sciences Research Council, the Executive Chair of the World Innovation Summit for Health, as the Chair of Surgery at Imperial College London and as Professor of Surgery at the Institute of Cancer Research. From 2013 to 2015, Lord Darzi served as the Vice-Dean of Health Policy and Engagement at the Imperial College of London. Lord Darzi received his Medical Degree from Trinity College.
What is the salary of Lord Darzi?
As the Independent Director of Evelo Biosciences Inc, the total compensation of Lord Darzi at Evelo Biosciences Inc is $114,666. There are 4 executives at Evelo Biosciences Inc getting paid more, with Balkrishan Gill having the highest compensation of $2,802,000.
How old is Lord Darzi?
Lord Darzi is 59, he's been the Independent Director of Evelo Biosciences Inc since 2018. There are 4 older and 9 younger executives at Evelo Biosciences Inc. The oldest executive at Evelo Biosciences Inc is Stephen J. Carriere, 66, who is the VP & Chief Accounting Officer.
What's Lord Darzi's mailing address?
Lord's mailing address filed with the SEC is C/O EVELO BIOSCIENCES, INC., 620 MEMORIAL DRIVE, CAMBRIDGE, MA, 02139.
Insiders trading at Evelo Biosciences Inc
Over the last 7 years, insiders at Evelo Biosciences Inc have traded over $41,656 worth of Evelo Biosciences Inc stock and bought 38,579,214 units worth $81,620,674 . The most active insiders traders include Ventures Fund Iv General Pa..., Noubar Afeyan oraz Ventures Fund Iv General Pa.... On average, Evelo Biosciences Inc executives and independent directors trade stock every 45 days with the average trade being worth of $19,676. The most recent stock trade was executed by Mark Bodmer on 7 November 2023, trading 6,625 units of EVLO stock currently worth $149.
What does Evelo Biosciences Inc do?
evelo biosciences is dedicated to improving the lives of patients globally through the development of a new modality of medicines – monoclonal microbials. monoclonal microbials are orally delivered medicines that modulate systemic immunology and biology through direct interactions with human cells in the gut. these new medicines are broadly applicable across many diseases – including autoimmune, immunoinflammatory, metabolic, neurological, neuroinflammatory diseases and cancer. monoclonal microbials have the potential to fundamentally change traditional models of drug discovery and development. by finding and selecting naturally occurring monoclonal microbials with defined therapeutic effects, evelo can improve the speed, cost and success of drug discovery and development. evelo’s platform enables pharmacological intervention at all stages of disease with naturally occurring, safe and effective monoclonal microbials. evelo biosciences was conceived and created within venturelabs®, flag
What does Evelo Biosciences Inc's logo look like?
Complete history of Lord Darzi stock trades at Evelo Biosciences Inc
Evelo Biosciences Inc executives and stock owners
Evelo Biosciences Inc executives and other stock owners filed with the SEC include:
-
Balkrishan Gill,
President, Chief Executive Officer, Principal Financial Officer, Treasurer, Director -
Mark Bodmer,
Chief Scientific Officer, President of Research and Development -
David Epstein,
Chairman of the Board -
Theodose Melas-Kyriazi,
Independent Director -
Nancy Simonian,
Independent Director -
Lord Ara Darzi,
Independent Director -
David Perry,
Independent Director -
Juan Andres,
Independent Director -
Duncan McHale,
Chief Medical Officer -
Daniel Char,
General Counsel, Secretary -
Xiaoli Liu,
Principal Accounting Officer, Controller -
Leslie Wardwell-Scott Ph.D.,
Head of Corp. Devel. & Strategic Integration -
Jessica Cotrone,
VP & Head of Communications -
Daniel S. Char,
Gen. Counsel & Sec. -
Kendra Sweeney,
Head of Investor Relations & Capital Markets -
Dr. Chun Zhang,
Head of Technical Operations -
Stephen J. Carriere,
VP & Chief Accounting Officer -
Luca Scavo,
CFO, Sr. VP & Treasurer -
Dr. Duncan McHale M.D., Ph.D.,
Chief Medical Officer -
Dr. Balkrishan Gill Ph.D.,
Pres, CEO & Director -
Julie Mc Hugh,
Director -
Alexander C Reynolds,
Director -
Jeffrey R. Moore,
Director -
Kyriazi Theo Melas,
Director -
Noubar Afeyan,
Director -
Ventures Fund Iv General Pa...,
-
Jose Carlos Gutierrez Ramos,
Director -
Simba Gill,
President & CEO -
Jonathan Poole,
CFO -
Ventures Fund Iv General Pa...,
-
Ventures Fund V General Par...,
-
Robert L. Rosiello,
Director -
Tonya Williams,
Director -
Iain B. Mc Innes,
Director -
Neil Graham,
Chief Development Officer -
Ventures Fund Iv General Pa...,
-
Ventures Fund Iv General Pa...,
-
Jonathan B. Zung,
Chief Development Officer -
John Hohneker,
Director -
Stephen J Carriere,
Principal Accounting Officer -
Mark D. Plinio,
Chief Commercial Officer -
Luca Scavo,
CFO -
Ventures Fund Iv General Pa...,
-
Marella Thorell,
Chief Financial Officer